Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2013
03/14/2013WO2012174139A3 Compositions and methods for making and b ioc ont aining auxotrophic transgenic plants
03/14/2013WO2012174126A8 METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY
03/14/2013WO2012173390A3 Method for enhancing the production yield of human papillomavirus l1 protein
03/14/2013WO2012170842A3 Peptide for protection of allergic respiratory disorders
03/14/2013WO2012162211A3 Antisense oligonucleotides against neutral sphingomyelinase and neutral sphingomyelinase inhibitor gw4869 for degenerative neurological disorders
03/14/2013WO2012161491A3 Plant disease resistance-related gene derived from a soil metagenome and uses thereof
03/14/2013WO2012149562A3 Selective anti-hla antibody removal device and methods of production and use thereof
03/14/2013WO2012149356A3 Anti-cd40 antibodies and methods of use
03/14/2013WO2012146171A9 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/14/2013WO2012145725A3 Oscillating amplification reaction for nucleic acids
03/14/2013WO2012143477A3 Anticancer fusion protein
03/14/2013WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein
03/14/2013WO2012129548A3 In situ expression of lipase for enzymatic production of alcohol esters during fermentation
03/14/2013WO2012129373A3 Methods for producing a complex transgenic trait locus
03/14/2013WO2012125737A3 Methods for increasing carbon fixation
03/14/2013WO2012112925A9 Quantitative, highly multiplexed detection of nucleic acids
03/14/2013WO2012094307A3 Gene and variations associated with bm1 phenotype, molecular markers, and their use
03/14/2013WO2012068463A3 Methods of treating obesity by inhibiting nicotinamide n-methyl transferase (nnmt)
03/14/2013WO2011133890A8 Cns targeting aav vectors and methods of use thereof
03/14/2013WO2010085101A9 Novel lipases induced by fasting
03/14/2013US20130067620 Improved Compositions and Methods for Pathogen Control in Plants
03/14/2013US20130067619 Genes and proteins for aromatic polyketide synthesis
03/14/2013US20130067618 Methods and compositions for weed control
03/14/2013US20130067617 Plants having stress related traits and methods for making the same
03/14/2013US20130067616 Plant Defensive Peptides
03/14/2013US20130067615 Soybean cultivar s100322
03/14/2013US20130067614 Soybean cultivar s100312
03/14/2013US20130067613 Soybean cultivar s100282
03/14/2013US20130067612 Soybean cultivar 94l41
03/14/2013US20130067611 Soybean cultivar s100319
03/14/2013US20130067610 Broccoli hybrid rs05151611 and parents thereof
03/14/2013US20130067608 Colon cancer targets and uses thereof
03/14/2013US20130067607 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
03/14/2013US20130067606 Modulating production traits in avians
03/14/2013US20130067605 hnRNP A1 KNOCKOUT ANIMAL MODEL AND USE THEREOF
03/14/2013US20130066402 Engineered red-shifted channelrhodopsin variants
03/14/2013US20130066234 Vessel for blood sampling
03/14/2013US20130066060 Gene for Identifying Individuals with Familial Dysautonomia
03/14/2013US20130066058 Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1
03/14/2013US20130066052 Ucp4
03/14/2013US20130066051 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
03/14/2013US20130066047 Red-shifted channelrhodopsins
03/14/2013US20130065953 Phenotypic reversion of pancreatic carcinoma cells
03/14/2013US20130065952 Tumor-specific promoter and oncolytic virus vector comprising the same
03/14/2013US20130065951 Compositions and methods related to mirna modulation of neovascularization or angiogenesis
03/14/2013US20130065950 Modified oligonucleotides for telomerase inhibition
03/14/2013US20130065948 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
03/14/2013US20130065943 Compositions and methods for inhibiting expression of cd45 gene
03/14/2013US20130065942 Nucleic Acid-Lipopolymer Compositions
03/14/2013US20130065941 Compositions and their uses for gene therapy of bone conditions
03/14/2013US20130065834 Modulators of proteasome activity
03/14/2013US20130065829 Peptides and supported peptides for treating skin diseases
03/14/2013US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv
03/14/2013US20130065814 Inductive production of pluripotent stem cells using synthetic transcription factors
03/14/2013US20130065810 Novel Fungal Protease and Use Thereof
03/14/2013US20130065792 Inducible expression of sglt5, methods and kits using the same
03/14/2013US20130065761 Methods for Increasing the Resistance of Plants to Hypoxic Conditions
03/14/2013US20130065314 Algal transformation systems, compositions and methods
03/14/2013US20130065313 Molecular biology tools for algal engineering
03/14/2013US20130065312 Method and composition for generating programmed cell death resistant algal cells
03/14/2013US20130065311 Method of nuclear reprogramming
03/14/2013US20130065310 Use of endogenous promoters to express heterologous proteins
03/14/2013US20130065309 Preparation of Negative-Stranded RNA Viruses By Electroporation
03/14/2013US20130065308 Cationic lipids
03/14/2013US20130065307 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture
03/14/2013US20130065299 Actriib-fc polynucleotides, polypeptides, and compositions
03/14/2013US20130065298 siRNA-MEDIATED GENE SILENCING
03/14/2013US20130065284 Modified microorganism for highly efficient production of lactic acid
03/14/2013US20130065278 Production of proteins and polypeptides
03/14/2013US20130065276 Compositions and methods of treating disease with fgfr fusion proteins
03/14/2013US20130065275 Serum-free mammalian cell culture medium, and uses thereof
03/14/2013US20130065270 Non-Recombinant Saccharomyces Strains that Grow on Xylose
03/14/2013US20130065261 Modified glucose dehydrogenase gene
03/14/2013US20130065243 Method for producing induced pluripotent stem cells
03/14/2013US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
03/14/2013US20130065227 Methods of increasing macropinocytosis in cancer cells
03/14/2013US20130064960 Cucumber variety nun 55506 cup
03/14/2013US20130064959 New melon variety nun 02602 me
03/14/2013US20130064881 Compositions and methods for treating prostate cancer
03/14/2013US20130064879 Compositions and Methods for Inhibiting Viral Replication
03/14/2013US20130064853 Parasite vaccine
03/14/2013US20130064851 Inactivated staphylococcal whole-cell vaccine
03/14/2013US20130064850 Using Modified Plasmids to Suppress Antibiotic Resistant Pathogens
03/14/2013US20130064846 Neisserial antigens
03/14/2013US20130064844 Non-splicing variants of gp350/220
03/14/2013US20130064840 Hjurp peptides and vaccines including the same
03/14/2013US20130064837 Integrin alpha-v beta8 neutralizing antibody
03/14/2013US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5
03/14/2013US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
03/14/2013US20130064823 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
03/14/2013US20130064817 Engineered anti-il-23r antibodies
03/14/2013US20130064814 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells
03/14/2013US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
03/14/2013US20130064805 Highly functional enzyme having alpha-galactosidase activity
03/14/2013US20130064801 Cellular Compositions and Methods of Making and Using Them
03/14/2013US20130064792 Therapy for influenza like illness
03/14/2013US20130064791 Interferon Analogs
03/14/2013US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10)
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 4023